These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35590037)

  • 41. Clinical characteristics of Japanese pustular psoriasis: A multicenter observational study.
    Ohata C; Tsuruta N; Yonekura K; Higashi Y; Saito K; Katayama E; Imafuku S;
    J Dermatol; 2022 Jan; 49(1):142-150. PubMed ID: 34723399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploring the Quality-of-Life Impact, Disease Burden, and Management Challenges of GPP: The Provider and Patient Perspective [Podcast].
    Hawkes JE; Reisner DV; Bhutani T
    Clin Cosmet Investig Dermatol; 2023; 16():3333-3339. PubMed ID: 38021429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation.
    Potestio L; Camela E; Cacciapuoti S; Martora F; Guerriero L; Fornaro L; Ruggiero A; Megna M
    Expert Opin Drug Saf; 2023; 22(11):1003-1010. PubMed ID: 37768729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A brief guide to pustular psoriasis for primary care providers.
    Crowley JJ; Pariser DM; Yamauchi PS
    Postgrad Med; 2021 Apr; 133(3):330-344. PubMed ID: 33118424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors associated with generalized pustular psoriasis progression among patients with psoriasis vulgaris in Japan: Results from a claims database study.
    Hayama K; Iwasaki R; Tian Y; Fujita H
    J Dermatol; 2023 Dec; 50(12):1531-1538. PubMed ID: 37721393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Economic Burden of Generalized Pustular Psoriasis in Sweden: A Population-Based Register Study.
    Löfvendahl S; Norlin JM; Schmitt-Egenolf M
    Psoriasis (Auckl); 2022; 12():89-98. PubMed ID: 35548662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Economic burden of generalized pustular psoriasis and palmoplantar pustulosis in the United States.
    Hanna ML; Singer D; Valdecantos WC
    Curr Med Res Opin; 2021 May; 37(5):735-742. PubMed ID: 33622113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gastrointestinal and hepatic manifestations in patients with generalised pustular psoriasis.
    Lim LY; Oon HH
    Exp Dermatol; 2023 Aug; 32(8):1246-1252. PubMed ID: 36779689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and genetic differences between pustular psoriasis subtypes.
    Twelves S; Mostafa A; Dand N; Burri E; Farkas K; Wilson R; Cooper HL; Irvine AD; Oon HH; Kingo K; Köks S; Mrowietz U; Puig L; Reynolds N; Tan ES; Tanew A; Torz K; Trattner H; Valentine M; Wahie S; Warren RB; Wright A; Bata-Csörgő Z; Szell M; Griffiths CEM; Burden AD; Choon SE; Smith CH; Barker JN; Navarini AA; Capon F
    J Allergy Clin Immunol; 2019 Mar; 143(3):1021-1026. PubMed ID: 30036598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia.
    Choon SE; Lai NM; Mohammad NA; Nanu NM; Tey KE; Chew SF
    Int J Dermatol; 2014 Jun; 53(6):676-84. PubMed ID: 23967807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unmet Educational Needs and Clinical Practice Gaps in the Management of Generalized Pustular Psoriasis: Global Perspectives from the Front Line.
    Strober B; Leman J; Mockenhaupt M; Nakano de Melo J; Nassar A; Prajapati VH; Romanelli P; Seneschal J; Tsianakas A; Wei LY; Yasuda M; Yu N; Hernandez Daly AC; Okubo Y
    Dermatol Ther (Heidelb); 2022 Feb; 12(2):381-393. PubMed ID: 34904208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploring content and psychometric validity of newly developed assessment tools for itch and skin pain in atopic dermatitis.
    Newton L; DeLozier AM; Griffiths PC; Hill JN; Hudgens S; Symonds T; Gable JC; Paik J; Wyrwich KW; Eichenfield LF; Abetz-Webb L; Silverberg JI
    J Patient Rep Outcomes; 2019 Jul; 3(1):42. PubMed ID: 31312940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosis and screening of patients with generalized pustular psoriasis.
    Ly K; Beck KM; Smith MP; Thibodeaux Q; Bhutani T
    Psoriasis (Auckl); 2019; 9():37-42. PubMed ID: 31417859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A narrative review of studies assessing the quality of life in patients with generalized pustular psoriasis.
    Patel PM; Sanchez-Melendez SN; Nambudiri VE
    Exp Dermatol; 2023 Aug; 32(8):1227-1234. PubMed ID: 36922363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Generalized pustular psoriasis: A global Delphi consensus on clinical course, diagnosis, treatment goals and disease management.
    Puig L; Choon SE; Gottlieb AB; Marrakchi S; Prinz JC; Romiti R; Tada Y; von Bredow D; Gooderham M
    J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):737-752. PubMed ID: 36606566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gastrointestinal bleeding with severe mucosal involvement in a patient with generalized pustular psoriasis without IL36RN mutation.
    Komatsuda S; Kamata M; Chijiwa C; Namiki K; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Abe K; Yamamoto T; Aozasa N; Sugiura K; Tada Y
    J Dermatol; 2019 Jan; 46(1):73-75. PubMed ID: 30474867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A review of disease burden and clinical management for generalized pustular psoriasis in China.
    Lu J; Shi Y
    Expert Rev Clin Immunol; 2022 Oct; 18(10):1023-1032. PubMed ID: 36040447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reliability, validity, and the ability to detect change of the Psoriasis Symptom Scale (PSS) in patients with plaque psoriasis.
    Rentz AM; Skalicky AM; Esser D; Zema C; Becker K; Bodhani A; Revicki DA
    J Dermatolog Treat; 2020 Aug; 31(5):460-469. PubMed ID: 32045314
    [No Abstract]   [Full Text] [Related]  

  • 59. Juvenile generalized pustular psoriasis is a chronic recalcitrant disease: an analysis of 27 patients seen in a tertiary hospital in Johor, Malaysia.
    Lau BW; Lim DZ; Capon F; Barker JN; Choon SE
    Int J Dermatol; 2017 Apr; 56(4):392-399. PubMed ID: 28194751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic Efficacy of Interleukin 12/Interleukin 23 Blockade in Generalized Pustular Psoriasis Regardless of IL36RN Mutation Status.
    Arakawa A; Ruzicka T; Prinz JC
    JAMA Dermatol; 2016 Jul; 152(7):825-8. PubMed ID: 27096382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.